Rohto Pharmaceutical Co.,Ltd.
4527
Rangering i aksjer
#3854
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Aksjekurs
$19.03
Markedsverdi
$4.30B
Endring (1 dag)
0.15%
Endring (1 år)
16.15%
Land
JP
Handel Rohto Pharmaceutical Co.,Ltd. (4527)
Kategori
Consumer Defensive
Inntekter for Rohto Pharmaceutical Co.,Ltd. (4527)
Inntekter i Jun 2026 TTM: $303.71M
Ifølge Rohto Pharmaceutical Co.,Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat $303.71M. I 2024 hadde selskapet et resultat på $274.31M, en økning sammenlignet med resultatet i 2023, som var $258.26M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Rohto Pharmaceutical Co.,Ltd. fra 2008 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $303.71M | 7.55% |
| 2025 | $282.40M | 2.95% |
| 2024 | $274.31M | 6.21% |
| 2023 | $258.26M | 12.49% |
| 2022 | $229.58M | 10.53% |
| 2021 | $207.71M | 2.77% |
| 2020 | $202.12M | 37.64% |
| 2019 | $146.85M | -7.24% |
| 2018 | $158.31M | 19.53% |
| 2017 | $132.44M | 4.19% |
| 2016 | $127.12M | 10.88% |
| 2015 | $114.65M | -19.00% |
| 2014 | $141.54M | -2.14% |
| 2013 | $144.64M | -14.82% |
| 2012 | $169.81M | 4.81% |
| 2011 | $162.02M | 21.98% |
| 2010 | $132.83M | 41.40% |
| 2009 | $93.94M | -24.26% |
| 2008 | $124.03M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $20.38B | 6,609.37% |
US
|
|
| $9.83B | 3,135.44% |
FR
|
|
| $2.94B | 868.36% |
US
|
|
| $1.55B | 410.35% |
IN
|
|
| $517.00M | 70.23% |
US
|
